Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
45.11
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Debt to Equity Ratio : 0.039 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.039 |
| March 31, 2026 | 0.038 |
| December 31, 2025 | 0.0386 |
| September 30, 2025 | 0.0402 |
| June 30, 2025 | 0.0299 |
| March 31, 2025 | 0.0313 |
| December 31, 2024 | 0.0331 |
| September 30, 2024 | 0.0379 |
| June 30, 2024 | 0.0418 |
| March 31, 2024 | 0.0453 |
| December 31, 2023 | 0.0451 |
| September 30, 2023 | 0.0464 |
| June 30, 2023 | 0.0459 |
| March 31, 2023 | 0.5755 |
| December 31, 2022 | 0.5019 |
| September 30, 2022 | 0.5209 |
| June 30, 2022 | 0.5305 |
| March 31, 2022 | 0.5434 |
| December 31, 2021 | 0.5234 |
| September 30, 2021 | 0.5257 |
| June 30, 2021 | 0.5378 |
| March 31, 2021 | 0.5749 |
| December 31, 2020 | 0.5793 |
| September 30, 2020 | 0.6116 |
| June 30, 2020 | 0.6465 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6611 |
| December 31, 2019 | 0.6733 |
| September 30, 2019 | 0.7085 |
| June 30, 2019 | 0.7494 |
| March 31, 2019 | 0.8099 |
| December 31, 2018 | 0.7819 |
| September 30, 2018 | 0.8316 |
| June 30, 2018 | 0.8898 |
| March 31, 2018 | 0.9777 |
| December 31, 2017 | 0.0992 |
| September 30, 2017 | 0.1111 |
| June 30, 2017 | 0.1336 |
| March 31, 2017 | 0.1626 |
| December 31, 2016 | 0.1802 |
| September 30, 2016 | 0.0333 |
| June 30, 2016 | 0.0517 |
| March 31, 2016 | 0.0579 |
| December 31, 2015 | 0.4274 |
| September 30, 2015 | 0.0737 |
| June 30, 2015 | 0.1199 |
| March 31, 2015 | 0.18 |
| December 31, 2014 | 0.3777 |
| September 30, 2014 | 0.4007 |
| June 30, 2014 | 0.8592 |
| March 31, 2014 | 0.9774 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Indivior Pharmaceuticals, Inc. | -2.447 |
| Pfizer Inc. | 0.7418 |
| Amphastar Pharmaceuticals, Inc. | 0.8961 |
| Collegium Pharmaceutical, Inc. | 3.905 |
| Bristol Myers Squibb Co. | 2.019 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.428B |
| Total Liabilities (Quarterly) | 396.88M |
| Shareholders Equity (Quarterly) | 1.031B |
| Current Ratio | 2.083 |
| Net Debt Paydown Yield | -0.06% |